Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod Extension Study in Relapsing Multiple Sclerosis
NCT00670449Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2008
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Started Apr 2008; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00670449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670449.